SFX by Ex Libris Inc.

Title:	Glucose-dependent insulin release from genetically engineered K cells
Source:	Science [0036-8075] Cheung, A T yr:2000

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Fujita, Y. "Harnessing the gut to treat diabetes." Pediatric diabetes 5 Suppl 2 (2004): 57-69.
description	2.	Cline, G W W. "Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes." The New England journal of medicine 341.4 (1999): 240-6.
description	3.	Yoon, Ji-Won W. "Recent advances in insulin gene therapy for type 1 diabetes." Trends in molecular medicine 8.2 (2002): 62-8.
description	4.	Thomas, Wayne R R. "Genetically engineered vaccines." Current Allergy and Asthma Reports 5.3 (2005): 197-203.
description	5.	Corbett, J A A. "K cells: a novel target for insulin gene therapy for the prevention of diabetes." Trends in Endocrinology and Metabolism 00012.00004 (2001): 140-2.
description	6.	Kahn, A. "Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance." Nature medicine 6.8 (2000): 924-8.
description	7.	Cheroutre, H. "The light and dark sides of intestinal intraepithelial lymphocytes." Nature reviews. Immunology 11.7 (2011): 445-456.
description	8.	Ramshur, Erin B. "Novel insulin/GIP co-producing cell lines provide unexpected insights into gut K-cell function in vivo." Journal of cellular physiology 192.3 (2002): 339-350.
description	9.	Krieg, RJ. "Growth hormone and growth hormone-related mRNA in uremic rats: effect of a growth hormone secretagogue." Pediatric nephrology 17.8 (2002): 585-590.
description	10.	Getty, L. "Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile." Diabetes 47.12 (1998): 1941-1947.
description	11.	Lambeir, Anne-Marie M. "Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV." Critical reviews in clinical laboratory sciences 40.3 (2003): 209-94.
description	12.	Manzoni, M. "Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs." Applied microbiology and biotechnology 58.5 (2002): 555-564.
description	13.	Sudduth, Mary A. "Genetically engineered foods--fears & facts." FDA Consumer 27.1 (1993): 10-14.
description	14.	Hotamisligil, Gökhan S S. "Inflammation and metabolic disorders." Nature 444.7121 (2007): 860-7.
description	15.	Liu, Z. "Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future." Cell Transplant 26.6: 925-947.
description	16.	Fauci, Anthony S. "Toward an HIV vaccine: A scientific journey." Science 349.6246 (2015): 386-387.
description	17.	Kolarova, T. "HIGH SCHOOL STUDENTS' REASONING IN MAKING DECISIONS ABOUT SOCIO-ETHICAL ISSUES OF GENETIC ENGINEERING: CASE OF GENE THERAPY." Biotechnology & Biotechnological Equipment 27.2 (2013): 3737-3747.
description	18.	Tang, S. "Development of genetically engineered human intestinal cells for regulated insulin secretion using rAAV-mediated gene transfer." Biochemical and biophysical research communications 303.2 (2003): 645-52.
description	19.	Stefani, S. "Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance." International Journal of Infectious Diseases; IJID 14.4: 19-22.
description	20.	Stevceva, L. "Targeting the mucosa: genetically engineered vaccines and mucosal immune responses." Genes and Immunity 1.5 (2000): 308-315.